|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 286.69 USD | +0.50% |
|
-0.48% | +4.16% |
| 05-14 | Cigna Insider Sold Shares Worth $59,114,186, According to a Recent SEC Filing | MT |
| 05-13 | The Cigna Group Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 09:20 AM |
Company Valuation: Cigna
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 76,106 | 101,304 | 87,625 | 76,809 | 73,521 | 75,839 | - | - |
| Change | - | 33.11% | -13.5% | -12.34% | -4.28% | 3.15% | - | - |
| Enterprise Value (EV) 1 | 104,695 | 126,473 | 110,733 | 101,231 | 97,308 | 94,431 | 91,380 | 84,966 |
| Change | - | 20.8% | -12.45% | -8.58% | -3.88% | -2.96% | -3.23% | -7.02% |
| P/E ratio | 14.6x | 15.6x | 17.2x | 22.8x | 12.4x | 11.3x | 9.84x | 8.91x |
| PBR | 1.57x | 2.21x | 1.89x | 1.84x | 1.74x | 1.7x | 1.57x | 1.28x |
| PEG | - | 0.4x | -0.9x | -0.8x | 0.1x | 0.8x | 0.6x | 0.9x |
| Capitalization / Revenue | 0.44x | 0.56x | 0.45x | 0.31x | 0.27x | 0.27x | 0.25x | 0.24x |
| EV / Revenue | 0.6x | 0.7x | 0.57x | 0.41x | 0.35x | 0.33x | 0.31x | 0.27x |
| EV / EBITDA | 9.42x | 11x | 9.24x | 8.38x | 7.88x | 7.11x | 6.35x | 5.66x |
| EV / EBIT | 13.2x | 15x | 13x | 10.7x | 10.6x | 9.61x | 8.36x | 7.66x |
| EV / FCF | 17.3x | 17.2x | 10.8x | 11.3x | - | 10.4x | 9.04x | 8.4x |
| FCF Yield | 5.77% | 5.82% | 9.25% | 8.85% | - | 9.57% | 11.1% | 11.9% |
| Dividend per Share 2 | 4 | 4.48 | 4.92 | 5.6 | - | 6.178 | 6.447 | 6.75 |
| Rate of return | 1.74% | 1.35% | 1.64% | 2.03% | - | 2.15% | 2.25% | 2.35% |
| EPS 2 | 15.73 | 21.3 | 17.39 | 12.12 | 22.18 | 25.3 | 29.15 | 32.16 |
| Distribution rate | 25.4% | 21% | 28.3% | 46.2% | - | 24.4% | 22.1% | 21% |
| Net sales 1 | 174,078 | 180,642 | 195,322 | 247,099 | 274,900 | 284,004 | 297,643 | 311,937 |
| EBITDA 1 | 11,118 | 11,522 | 11,980 | 12,083 | 12,351 | 13,286 | 14,385 | 15,013 |
| EBIT 1 | 7,935 | 8,414 | 8,536 | 9,417 | 9,200 | 9,823 | 10,933 | 11,093 |
| Net income 1 | 5,365 | 6,668 | 5,164 | 3,434 | 5,957 | 6,622 | 7,728 | 7,884 |
| Net Debt 1 | 28,589 | 25,169 | 23,108 | 24,422 | 23,787 | 18,592 | 15,541 | 9,127 |
| Reference price 2 | 229.63 | 331.34 | 299.45 | 276.14 | 275.23 | 286.69 | 286.69 | 286.69 |
| Nbr of stocks (in thousands) | 331,428 | 305,739 | 292,620 | 278,153 | 267,126 | 264,532 | - | - |
| Announcement Date | 2/3/22 A | 2/3/23 A | 2/2/24 A | 1/30/25 A | 2/5/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 11.28x | 0.33x | 7.08x | 2.17% | 75.46B | ||
| 23x | 0.91x | 14.31x | 2.25% | 358B | ||
| 19.18x | 0.56x | 10.95x | 1.77% | 85.28B | ||
| 37.42x | 0.28x | 16.44x | 1.17% | 36.63B | ||
| 23.62x | 0.13x | 12.43x | -.--% | 28.77B | ||
| 53.35x | 0.19x | 12.22x | -.--% | 9.64B | ||
| 82.22x | 0.54x | 18.19x | -.--% | 3.25B | ||
| 236.05x | 0.58x | 29.21x | -.--% | 1.83B | ||
| 17.88x | 1.2x | 6.96x | -.--% | 1.82B | ||
| 52x | 2.94x | 15.5x | 0.53% | 300M | ||
| Average | 55.60x | 0.77x | 14.33x | 0.79% | 60.07B | |
| Weighted average by Cap. | 23.35x | 0.70x | 12.97x | 1.93% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- CI Stock
- Valuation Cigna
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















